Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Oncology

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2014.2769PMID 25421824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic strategies for treating osteolytic bone metastases.

  2014cited by this paper
• Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup.

  2014cited by this paper
• Bisphophonates related osteonecrosis of the jaw

  2013cited by this paper
• Critical Role of AKT Protein in Myeloma-induced Osteoclast Formation and Osteolysis*

  2013cited by this paper
• Role of RANKL/RANK in primary and secondary breast cancer.

  2013cited by this paper
• Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt

  2012cited by this paper
• Bone metastasis in breast cancer: the story of RANK-ligand.

  2012cited by this paper
• Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade

  2012cited by this paper
• Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292

  2011cited by this paper
• Lung Tumor-associated Osteoblast-derived Bone Morphogenetic Protein-2 Increased Epithelial-to-Mesenchymal Transition of Cancer by Runx2/Snail Signaling Pathway*

  2011cited by this paper
• Cancer to bone: a fatal attraction

  2011cited by this paper
• OPG/RANKL/RANK pathway as a therapeutic target in cancer.

  2011cited by this paper
• Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.

  2011cited by this paper
• Breast cancer metastasis to the bone: mechanisms of bone loss

  2010cited by this paper
• New immune connections in osteoclast formation

  2010cited by this paper
• Metastatic cancer in solid tumors and clinical outcome: skeletal-related events.

  2009cited by this paper
• Bone growth during rapamycin therapy in young rats

  2009cited by this paper
• Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice

  2009cited by this paper
• Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo

  2009cited by this paper
• Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells.

  2008cited by this paper
• Hair growth promoting activity of Eclipta alba in male albino rats

  2008cited by this paper
• Simultaneous Estimation of Andrographolide and Wedelolactone in Herbal Formulations

  2008cited by this paper
• Biology of breast cancer bone metastasis

  2008cited by this paper
• HIV‐1 protease and HIV‐1 integrase inhibitory substances from Eclipta prostrata

  2007cited by this paper
• Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

  2007cited by this paper
• Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells.

  2007cited by this paper
• Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner.

  2006cited by this paper
• Akt1/Akt2 and Mammalian Target of Rapamycin/Bim Play Critical Roles in Osteoclast Differentiation and Survival, Respectively, Whereas Akt Is Dispensable for Cell Survival in Isolated Osteoclast Precursors*

  2005cited by this paper
• Mechanisms of bone metastasis.

  2004cited by this paper
• Mechanisms of bone metastasis.

  2004cited by this paper
• Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.

  2003cited by this paper
• Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities

  2002cited by this paper
• In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves.

  2001cited by this paper
• Therapeutic approaches to bone diseases.

  2000cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea.

  1986cited by this paper

• Wedelolactone, a natural coumestan with multiple pharmacological effects

  2026cites this paper
• Breaking Barriers; Phytoestrogens in the Fight Against Triple‐Negative Breast Cancer: A Comprehensive Review

  2025cites this paper
• Astragalin Attenuates Bone Destruction and the Progression of Bone Metastasis in Breast Cancer

  2025cites this paper
• Nanotechnology-Driven Treatment Strategies for Breast Cancer: Recent Advances and Innovations

  2025cites this paper
• Formononetin-induced apoptosis in hepatocellular carcinoma: insights from mTOR inhibition and caspase-3 activation through in silico and in vitro approaches.

  2025cites this paper
• The Role and Mechanism of RNA-binding Proteins in Bone Metabolism and Osteoporosis.

  2024cites this paper
• Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis

  2024cites this paper
• Coumarins as versatile therapeutic phytomolecules: A systematic review.

  2024cites this paper
• The search for an antiviral lead molecule to combat the neglected emerging Oropouche virus

  2024cites this paper
• HR-MAS NMR Metabolomics Profile of Vero Cells under the Influence of Virus Infection and nsP2 Inhibitor: A Chikungunya Case Study

  2024cites this paper
• Mechanisms by which kidney-tonifying Chinese herbs inhibit osteoclastogenesis: Emphasis on immune cells

  2023cites this paper
• Enhanced wedelolactone content in in vitro-raised genetically uniform Wedelia chinensis under the influence of CuSO4

  2023cites this paper
• Bioprospecting microbes and enzymes for the production of pterocarpans and coumestans

  2023cites this paper
• Potential Phytochemicals for Prevention of Familial Breast Cancer with BRCA Mutations.

  2023cites this paper
• Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer

  2023cites this paper
• (E)-β-Trifluoromethyl vinylsulfones as antitumor agents: Synthesis and biological evaluations.

  2022cites this paper
• Wedelolactone: A molecule of interests.

  2022cites this paper
• Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation.

  2022cites this paper
• Wedelolactone facilitates the early development of parthenogenetically activated porcine embryos by reducing oxidative stress and inhibiting autophagy

  2022cites this paper
• Phosphoproteomic Profiling of Rat’s Dorsal Root Ganglia Reveals mTOR as a Potential Target in Bone Cancer Pain and Electro-Acupuncture’s Analgesia

  2021cites this paper
• AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review

  2021cites this paper
• Environmental pollutant N‐N′ethylnitrosourea‐induced leukemic NLRP3 inflammasome activation and its amelioration by Eclipta prostrata and its active compound wedelolactone

  2021cites this paper
• Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases

  2021cites this paper
• Bone anti-resorptive effects of coumarins on RANKL downstream cellular signaling: A systematic review of the literature.

  2021cites this paper
• Possible Therapeutic Use of Natural Compounds Against COVID-19

  2021cites this paper
• Naturally occurring coumestans from plants, their biological activities and therapeutic effects on human diseases.

  2021cites this paper
• Wedelolactone improves the renal injury induced by lipopolysaccharide in HK-2 cells by upregulation of protein tyrosine phosphatase non-receptor type 2

  2021cites this paper
• DDDT_A_261321 3841..3852

  2020cites this paper
• IDENTIFICATION AND IMPACT OF ARBUSCULAR MYCORRHIZAL FUNGI ON ECLIPTA PROSTRATA L.AND

  2020cites this paper
• Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment.

  2020cites this paper
• Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding

  2020cites this paper
• The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials

  2020cites this paper
• inhibits the differentiation of osteoclasts

  2020cites this paper
• 3‐(4‐methoxyl)‐1‐(2‐(4‐coumarin)prop)‐2‐en‐1‐one inhibits the differentiation of Gaoyou duck embryonic osteoclasts in vitro

  2019cites this paper
• A brief lightening on medicinal activity and Pharmacological profile of plant Eclipta prostrata: A Review

  2019cites this paper
• Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma

  2019cites this paper
• Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors

  2019influential citation
• The Coumarin Derivative 5′-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways

  2019cites this paper
• Mammalian target of rapamycin as a therapeutic target in osteoporosis

  2018cites this paper
• Pulsed electromagnetic fields inhibit osteoclast differentiation in RAW264.7 macrophages via suppression of the protein kinase B/mammalian target of rapamycin signaling pathway.

  2018cites this paper
• Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles

  2018cites this paper
• Identification of Genes Associated with Breast Cancer Metastasis to Bone on a Protein-Protein Interaction Network with a Shortest Path Algorithm.

  2017cites this paper
• Effect and mechanism of wedelolactone as antioxidant-coumestan on OH-treated mesenchymal stem cells

  2017cites this paper
• Protective effects of wedelolactone on dextran sodium sulfate induced murine colitis partly through inhibiting the NLRP3 inflammasome activation via AMPK signaling.

  2017cites this paper
• Effect of dark-colored maple syrup on cell proliferation of human gastrointestinal cancer cell

  2017cites this paper
• Wedelolactone Enhances Osteoblastogenesis but Inhibits Osteoclastogenesis through Sema3A/NRP1/PlexinA1 Pathway

  2016cites this paper
• Wedelolactone metabolism in rats through regioselective glucuronidation catalyzed by uridine diphosphate-glucuronosyltransferases 1As (UGT1As).

  2016cites this paper
• Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases

  2016cites this paper
• Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway

  2016cites this paper
• INSIGHTS INTO THE MOLECULAR DOCKING STUDY OF WEDELOLACTONE TO IMPROVE THE PERFORMANCE OF COMPUTER-AIDED DRUG DESIGN

  2016cites this paper
• Syringetin suppresses osteoclastogenesis mediated by osteoblasts in human lung adenocarcinoma.

  2015cites this paper
• Crystal structure of 3-bromoacetyl-6-chloro-2H-1-benzopyran-2-one

  2015cites this paper